BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 9166453)

  • 1. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Dupuis NP; Kusumoto T; Robinson MF; Liu F; Menon K; Teicher BA
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):423-9. PubMed ID: 7493063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
    Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
    In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF; Porter EA; Fischer JJ; Rockwell S
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
    Teicher BA; Sotomayor EA; Dupuis NP; Kusumoto T; Menon K
    J Cancer Res Clin Oncol; 1994; 120(10):593-8. PubMed ID: 7929530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
    Thomas CD; Chavaudra N; Martin L; Guichard M
    Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA; Crawford JM; Holden SA; Cathcart KN
    Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA; Herman TS; Jones SM
    Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
    Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
    Halpern HJ; Yu C; Peric M; Barth ED; Karczmar GS; River JN; Grdina DJ; Teicher BA
    Radiat Res; 1996 May; 145(5):610-8. PubMed ID: 8619027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
    Teicher BA; Holden SA; al-Achi A; Herman TS
    Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
    Hishikawa-itoh Y; Miyata N
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):781-7. PubMed ID: 2142500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Liu F; Yuan J; Ikebe M; Kakeji Y
    Int J Cancer; 1995 May; 61(5):732-7. PubMed ID: 7768649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE; Fish BL
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
    Teicher BA; Holden SA; Rose CM
    J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
    NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.